Cite
Sodium‐glucose co‐transporter‐2 (SGLT‐2) inhibitors and cancer: A meta‐analysis of randomized controlled trials.
MLA
Dicembrini, Ilaria, et al. “Sodium‐glucose Co‐transporter‐2 (SGLT‐2) Inhibitors and Cancer: A Meta‐analysis of Randomized Controlled Trials.” Diabetes, Obesity & Metabolism, vol. 21, no. 8, Aug. 2019, pp. 1871–77. EBSCOhost, https://doi.org/10.1111/dom.13745.
APA
Dicembrini, I., Nreu, B., Mannucci, E., & Monami, M. (2019). Sodium‐glucose co‐transporter‐2 (SGLT‐2) inhibitors and cancer: A meta‐analysis of randomized controlled trials. Diabetes, Obesity & Metabolism, 21(8), 1871–1877. https://doi.org/10.1111/dom.13745
Chicago
Dicembrini, Ilaria, Besmir Nreu, Edoardo Mannucci, and Matteo Monami. 2019. “Sodium‐glucose Co‐transporter‐2 (SGLT‐2) Inhibitors and Cancer: A Meta‐analysis of Randomized Controlled Trials.” Diabetes, Obesity & Metabolism 21 (8): 1871–77. doi:10.1111/dom.13745.